Physician profile
Ann Jea Lee
NPI 1740607290
$3,357.98
in general payments reported to CMS, 2019-2025
18 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $492 · 2022: $958 · 2023: $401 · 2024: $1,038 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237 · Travel and Lodging: $571 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.12 |
| Travel and Lodging | $571.22 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $800.00 | 2022 | |
| Intuitive Surgical, INC. | $699.22 | 2024 | |
| Abbvie INC. | $402.23 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $207.29 | 2021-2023 | Austedo Xr |
| Verrica Pharmaceuticals INC. | $180.02 | 2024 | Ycanth |
| Axogen | $171.94 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $139.66 | 2024 | Sotyktu |
| Grifols USA, LLC | $124.99 | 2021 | |
| Endo USA, INC. | $123.04 | 2025 | Xiaflex |
| Regeneron Healthcare Solutions, INC. | $113.70 | 2023 | Dupixent |
| Davol INC. | $89.58 | 2023 | Arista Ah Flexitip |
| Arcutis Biotherapeutics, INC. | $76.40 | 2023 | |
| Depuy Synthes Sales INC. | $53.93 | 2021 | |
| Vyne Pharmaceuticals INC. | $52.92 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.08 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $32.90 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Galderma Laboratories, L.P. | $32.71 | 2025 | Nemluvio |
| Medtronic, INC. | $18.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.